PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Mabwell (Shanghai) Bioscience Co., Ltd, Shanghai, 201210, China.\', \'Beijing Kohnoor Science & Technology Co., Ltd, Beijing, 102206, China.\', \'School of Life Sciences, Anhui University, Hefei, 230601, China.\', \'Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, Beijing, 100050, China.\', \'Ludwig Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, OX37DQ, United Kingdom.\', \'Mabwell (Shanghai) Bioscience Co., Ltd, Shanghai, 201210, China. Jinchao.zhang@mabwell.com.\', \'School of Life Sciences, Anhui University, Hefei, 230601, China. zhmin07@ahu.edu.cn.\', \'Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, Beijing, 100050, China. wanglan@nifdc.org.cn.\', \'Mabwell (Shanghai) Bioscience Co., Ltd, Shanghai, 201210, China. xun.gui@mabwell.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s42003-022-03207-0
?:doi
?:hasPublicationType
?:journal
  • Communications biology
is ?:pmid of
?:pmid
?:pmid
  • 35332252
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Antibody-dependent enhancement (ADE) of SARS-CoV-2 pseudoviral infection requires FcγRIIB and virus-antibody complex with bivalent interaction.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all